Diversity-oriented synthesis of functionalized Quinolin-2(1H)-ones via pd-catalyzed site-selective cross-coupling reactions

被引:46
作者
Wang, Zhiyong
Wang, Bing
Wu, He
机构
[1] Fudan Univ, Dept Chem, Shanghai 200433, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Organometall Chem, Shanghai 200032, Peoples R China
来源
JOURNAL OF COMBINATORIAL CHEMISTRY | 2007年 / 9卷 / 05期
关键词
D O I
10.1021/cc7000937
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Biologically active 3-amino-4-arylquinolin-2(1H)-ones and 3-alkenyl-4-arylquinolin-2(1H)-ones were synthesized in an efficient and concise manner, utilizing readily available 4-hydroxyquinolin-2(1H)-one as starting material. The key steps, which introduced selectivity and diversity in the synthesis, were the palladium-catalyzed site-selective Suzuki-Miyaura/Buchwald-Hartwig amination and Suzuki-Miyaura/Heck coupling reactions of 3-bromo-4-trifloxy-quinolin-2(1H)-one.
引用
收藏
页码:811 / 817
页数:7
相关论文
共 31 条
[1]   Streamlined processes for the synthesis of a farnesyl transferase inhibitor drug candidate [J].
Andresen, BM ;
Couturier, M ;
Cronin, B ;
D'Occhio, M ;
Ewing, MD ;
Guinn, M ;
Hawkins, JM ;
Jasys, VJ ;
LaGreca, SD ;
Lyssikatos, JP ;
Moraski, G ;
Ng, K ;
Raggon, JW ;
Stewart, AM ;
Tickner, DL ;
Tucker, JL ;
Urban, FJ ;
Vazquez, E ;
Wei, LL .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2004, 8 (04) :643-650
[2]   Synthesis routes towards the farnesyl protein transferase inhibitor ZARNESTRA™ [J].
Angibaud, PR ;
Venet, MG ;
Filliers, W ;
Broeckx, R ;
Ligny, YA ;
Muller, P ;
Poncelet, VS ;
End, DW .
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY, 2004, 2004 (03) :479-486
[3]  
BEIER N, 1994, HETEROCYCLES, V39, P117
[4]   3-Thio-quinolinone maxi-K openers for the treatment of erectile dysfunction [J].
Boy, KM ;
Guernon, JM ;
Sit, SY ;
Xie, K ;
Hewawasam, P ;
Boissard, CG ;
Dworetzky, SI ;
Natale, J ;
Gribkoff, VK ;
Lodge, N ;
Starrett, JE .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (20) :5089-5093
[5]   Design, synthesis, structural studies, biological evaluation, and computational simulations of novel potent AT1 angiotensin II receptor antagonists based on the 4-phenylquinoline structure [J].
Cappelli, A ;
Mohr, GL ;
Gallelli, A ;
Rizzo, M ;
Anzini, M ;
Vomero, S ;
Mennuni, L ;
Ferrari, F ;
Makovec, F ;
Menziani, MC ;
De Benedetti, PG ;
Giorgi, G .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (10) :2574-2586
[6]   Angiogenesis in cancer and other diseases [J].
Carmeliet, P ;
Jain, RK .
NATURE, 2000, 407 (6801) :249-257
[7]   Efficient syntheses of KDR kinase inhibitors using a Pd-catalyzed tandem C-N/Suzuki coupling as the key step [J].
Fang, Yuan-Qing ;
Karisch, Robert ;
Lautens, Mark .
JOURNAL OF ORGANIC CHEMISTRY, 2007, 72 (04) :1341-1346
[8]  
FERRER P, 1995, LIEBIGS ANN, P1895
[9]   Optimization of the indolyl quinolinone class of KDR (VEGFR-2) kinase inhibitors: effects of 5-amido- and 5-sulphonamido-indolyl groups on pharmacokinetics and hERG binding [J].
Fraley, ME ;
Arrington, KL ;
Buser, CA ;
Ciecko, PA ;
Coll, KE ;
Fernandes, C ;
Hartman, GD ;
Hoffman, WF ;
Lynch, JJ ;
McFall, RC ;
Rickert, K ;
Singh, R ;
Smith, S ;
Thomas, KA ;
Wong, BK .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (02) :351-355
[10]   Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 2. [J].
Freeman, GA ;
Andrews, CW ;
Hopkins, AL ;
Lowell, GS ;
Schaller, LT ;
Cowan, JR ;
Gonzales, SS ;
Koszalka, GW ;
Hazen, RJ ;
Boone, LR ;
Ferris, RG ;
Creech, KL ;
Roberts, GB ;
Short, SA ;
Weaver, K ;
Reynolds, DJ ;
Milton, J ;
Ren, JS ;
Stuart, DI ;
Stammers, DK ;
Chan, JH .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (24) :5923-5936